(Total Views: 711)
Posted On: 12/02/2023 10:17:08 AM
Post# of 148878
The terms of a current $1M offering waere discussed. There were several questions from investors presented and answered.
Said he thinks the FDA used the thee covid study cardiac cases as cover to implement the hold when the real problem was the SEC investigation.
He doesn't thingk the FDA will have a good reason to not approve another HIV study. Said based on what he's heard so far from FDA sounds promising.
Need an unambiguous study result that shows more than provacative signals that we've had so far in NASH/cancer/Covid.
Touched on the need to get the long acting leronlimab to get partnerships from big pharma as they want a once a month pill or injection vs the current formulation being weekly. He's had talks himself about this with Merck, Gilead etc.
Said he thinks the FDA used the thee covid study cardiac cases as cover to implement the hold when the real problem was the SEC investigation.
He doesn't thingk the FDA will have a good reason to not approve another HIV study. Said based on what he's heard so far from FDA sounds promising.
Need an unambiguous study result that shows more than provacative signals that we've had so far in NASH/cancer/Covid.
Touched on the need to get the long acting leronlimab to get partnerships from big pharma as they want a once a month pill or injection vs the current formulation being weekly. He's had talks himself about this with Merck, Gilead etc.
(12)
(0)Scroll down for more posts ▼
